ClinicalTrials.gov
ClinicalTrials.gov Menu

REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients (REPAIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01171209
Recruitment Status : Completed
First Posted : July 28, 2010
Last Update Posted : November 30, 2012
Sponsor:
Collaborator:
University of Copenhagen
Information provided by (Responsible Party):
Melinda Magyari, Rigshospitalet, Denmark

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2011
  Actual Study Completion Date : August 2011

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 June 19, 2013
August 30, 2013
2 September 11, 2013
November 12, 2013
3 November 18, 2013
January 6, 2014
4 January 8, 2014
February 26, 2014
5 July 11, 2014
August 5, 2014